The surgical management of melanoma becomes more important each year as an ever larger number of individuals are afflicted with this disease, which is increasing in incidence at an alarming rate. Of the more than 32,000 patients who developed the disease in 1990,1 about 12,800 (40%) had intermediate-thickness melanomas (i.e., 1.0 to 4.0 mm), for which the optimal excision margins have not been previously defined in a controlled surgical trial. Determining the appropriate margins is vitally important because of the adverse effects associated with suboptimal margins. If the margins are too narrow, residual tumor cells might eventually result in a local recurrence, a life-threatening process since 60% to 80% ofsuch patients eventually die oftheir disease.2 If the surgical margins are too wide, the large surgical defect may have to be covered with a split-thickness skin graft (STSG) or a complicated flap, which results in greater disfigurement, prolongs hospitalization, and increases costs.
Historically, the recommended surgical margins for melanoma have been a 4-to 5-cm radius around the primary tumor or the biopsy site. During the past decade, however, surgical margins have been reduced, largely based on empirical observations and retrospective studies.39 Retrospective studies have noted a correlation among the surgical margins, tumor thickness, and the incidence of local recurrences.2"'12 Only one prospective, randomized trial has been conducted, and it was restricted to melanomas thinner than 2.0 mm. ' The current study is the first to address the optimal surgical margins for intermediate-thickness melanomas (1.0 to 4.0 mm). We postulated that the lateral extent of these melanomas (including microsatellites) is less than 2 cm in a radial direction from the primary tumor or biopsy site.
METHODS Patients
All patients had cutaneous melanomas with thicknesses of 1.0 to 4.0 mm and no evidence of metastatic melanoma in regional lymph nodes or at distant sites. Patients who had had cancer previously (except for skin cancer) or who had received chemotherapy, radiotherapy, or any other adjunct to surgery were excluded. Patients with lentigo maligna melanoma were also excluded. Written informed consent was obtained from all patients.
Patients with clinically localized melanomas (i.e., Stages I and II according to American Joint Committee on Cancer staging criteria) and intermediate-thickness melanomas located on the trunk or a proximal extremity (i.e., proximal to the elbow or knee) were randomly assigned to receive either 2- 
Surgical Complications
A Surgical Toxicity Form was submitted within 3 months of surgery that described the presence and severity of wound infection, wound separations, seroma or hematoma, skin graft failure, limb edema, or prolonged pain. Other surgical complications such as thrombophlebitis and pneumonia were also reported.
Local Recurrences
A local recurrence was defined as a pathologically documented melanoma that recurred within 2 cm of the surgical scar after a definitive excision of the primary melanoma. All local recurrences were treated with complete excision of the lesion. If a patient with multiple in-transit (intralymphatic) metastases had a lesion within 2 cm of the scar, it was not counted as a local recurrence. Once the patient had distant metastases, synchronous tumor recurrences in and around the surgical scar were not counted as a local recurrence because they were more likely a manifestation of distant metastasis.
Statistical Analysis
Standard statistical techniques were used. Proportions were compared using chi square analysis or Fisher's exact test when appropriate. Mean comparisons were made using analysis of variance and t tests. Survival and disease recurrence curves were constructed using the Kaplan-Meier product limit method. These curves were analyzed for comparisons by the log-rank procedure. Proportional hazards analysis was used to associate covariates to time-dependent endpoints such as recurrence and survival.
The frequency oflocal recurrences increased as a function of time. To determine when the data base was sufficiently mature to close the study, Dr. Seng-jaw Soong examined the cumulative frequency of local recurrences among 294 patients with intermediate-thickness melanomas from the Alabama/Sydney Melanoma Data Base. More than 75% of local recurrences occurred within 24 months. Because the median follow-up time in this prospective, randomized trial has reached 72 months (and 80% of patients have been observed for more than 2 years), the number of patients still at risk for development of a local recurrence is small. Therefore, a decision was made to close the study and report the results.
RESULTS

Characteristics of Study Patients
Of the 486 patients entered in the study, 95.1% could be evaluated for response. Pathologic criteria rendered 1.2% ineligible for inclusion in the analysis; an additional 1.4% were excluded because their surgery violated protocol guidelines, and 2.3% were lost to follow-up.
The clinical and pathologic characteristics of the patients and their tumors are shown in Table 1 . The patients in the 2-cm and 4-cm margin subgroups were evenly distributed according to sex, age, anatomic site of the tumor, tumor thickness, and the presence or absence of tumor ulceration.
Skin Grafting Rate
Reducing the surgical margins significantly diminished the incidence of skin grafting (Table 2) . Thus, among patients who had 4-cm surgical margins, 46% required an STSG, compared with 11% of those who had 2-cm surgical margins (p < 0.001).
Duration of Hospital Stay
For the entire patient cohort, the length of hospital stay was shortened by almost 2 days for those who received 4-cm excision margins compared to those who received 2-cm margins (7.0 vs. 5.2 days, p < 0.001) (Table 2). For patients who did not have ELND, the hospital stay was reduced from 5.2 days for those who received 4-cm margins compared to 3.0 days for those who received 2-cm margins (p < 0.001) ( Table 2 ). 
Recurrence Rates
After a median follow-up time of72 months, the overall local recurrence rate was 0.8% (two patients) for those who received 2-cm excision margins and 1.7% (four patients) for those who received 4-cm margins (p = NS). The two patients with a local recurrence after a 2-cm margin had tumor thicknesses of 1.7 and 2.1 mm, while those with 4-cm margins had tumor thicknesses of 2.4, 2.9, 3.0, and 3.4 mm. Ofthese six patients, five have died ofmetastatic disease thus far. This finding reinforces previous conclusions that local recurrence is associated with a high mortality rate.25' The rates of in-transit metastases were virtually the same for both groups (2.5% vs. 2.1 %, respectively). The relapse rates for distant metastases were also comparable (10.9% vs. 8.5%, respectively; p = NS). (Fig.  1) . The overall 5-year survival rate was 79.5% for the 2-cm margin patients and 83.7% for the 4-cm margin patients (p = NS).
DISCUSSION
The results of this prospective, randomized trial demonstrated that it is safe to use 2-cm excision margins for intermediate-thickness melanomas. The local recurrence rates and survival rates were the same regardless of whether 2-or 4-cm surgical margins were used. In light of this finding, a 2-cm margin is clearly preferable because it significantly reduced the need for disfiguring skin grafts, was associated with a shortened hospital stay, and, by implication, reduced health care costs. Such a narrow excision could often be performed as outpatient surgery 
